Plain-English translation of NCT06628908 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can help reduce pain caused by diabetic peripheral neuropathy—nerve damage in the feet and legs that develops in people with diabetes. Researchers will compare how well works compared to a standard treatment () and a placebo (a pill with no active medicine) to understand if this new treatment is safe and effective.
Nerve pain from diabetes can be severe and difficult to treat, and many people don't get enough relief from existing medications. This trial is testing whether this medication might offer people with diabetic nerve pain a better option for managing their symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive either the new medication, the standard treatment, or a placebo—and neither you nor the study team will know which one you're getting. You'll take your assigned treatment daily and visit the clinic regularly so researchers can check how well it's working and monitor for any side effects. The study involves tracking your pain levels daily and completing follow-up visits over several months.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States